Daiken Biomedical Co., Ltd. (hereinafter referred to as “Daiken”) was established in 2018, primarily engaged in the research, development, and sales of health supplements. With the brand philosophy of “Your Health, Our Priority”, Daiken operates under the leadership of a professional R&D team headed by licensed pharmacist. The product portfolio covers various health needs, including cardiovascular health, vision care, probiotics series, and more, providing comprehensive health solutions for consumers of all ages.
Product Quality and International Certifications
Daiken is led by licensed pharmacist and comprises a professional biomedical team including PhD researchers from both domestic and international institutions. The team has studied thousands of international research papers, ensuring that every product has a solid scientific foundation. The company carefully selects premium ingredients from international suppliers and collaborates with leading manufacturers such as KD Pharma (Germany), KEMIN (United States), Probiotical (Italy), and Bioiberica (Spain) to develop health products. Daiken currently holds 44 global patents and has developed over 40 products, including high-concentration fish oil, lutein, bitter melon peptides, and probiotics.
Furthermore, Daiken has established stringent quality control mechanisms. A comprehensive supplier and manufacturer valuation system ensures that the specifications and concentrations of raw material and finished products consistently meet expected standards. Every batch undergoes complete third-party testing to safeguard consumers’ health. The Company’s products have been recognized with certifications such as Additive-Free Clean Label (AA), Monde Selection Quality Awards, Symbol of National Quality (SNQ), International Fish Oil Standards (IFOS), and International Probiotic Standards (IPRO).
Product Innovation and Distribution Network
Daiken provides a broad range of products, including solutions for blood glucose and lipid regulation, eye health, and digestive wellness, tailored to the needs of children, adults, and the elder. By integrating clinical research, biotechnology, and nutritional science, the Company drives product innovation and continuous optimization. Adjustments in formulations and dosage forms further enhance value-added benefits and strengthen market competitiveness.
Adopting an omni-channel strategy, Daiken integrates online and offline distribution. In the e-commerce sector, the company's official website serves as the primary sales platform, while simultaneously cooperating with four major e-commerce platforms, momo, Shopee, PChome, and Yahoo Shopping. The company is also progressively expanding into major drugstores, hypermarkets, pharmacy chains, and convenience stores, enabling consumers to access products more conveniently through diverse retail and wholesale channels, thereby building higher brand recognition and consumer connection.
Digital Advantages and Precision Marketing
Through AI-powered member analysis systems, Daiken delivers personalized product recommendations and tailored guidance on supplement use, thereby enhancing customer engagement and retention. By leveraging the influence of professional brand ambassadors, the company cultivates a strong and trustworthy brand image. Always adhering to the principle of "developing health products for family", Daiken adopts a consumer-centric, data-driven operating model that enables rapid responses to market demands and the continuous launch of innovative products aligned with consumer expectations.
Global Expansion and Future Outlook
Daiken is actively pursuing globalization. Its subsidiary in Japan has commenced operations, while additional subsidiaries in Hong Kong and Australia have been established to strengthen its presence in the Asia-Pacific region. With Japan serving as a strategic hub, the company plans to expand into Southeast Asia through cross-border e-commerce, while building an integrated supply chain and digital marketing ecosystem. Furthermore, Daiken plans to expand its brand portfolio in Japan and Australia through acquisitions, actively seeking potential targets with complementary product or channel advantages to accelerate regional growth and increase market share.
With a fully integrated system encompassing R&D, production, and sales, Daiken continues to expand its international footprint. The company is committed to reinforcing its existing technological advantages and channel foundation to continuously deepen patent technology development and brand value, combining international vision with localized operations to strengthen global market competitiveness. Combined with digital marketing strategies and big data health analytics, the company will continue to diversify its sales channels and strengthen its global market presence.